Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
new york blog main
new york top stories
abbvie
acorda therapeutics
akcea therapeutics
alnylam pharmaceuticals
ampyra
andrew fire
apokyn
apomorphine
boston
craig mello
dalfampridine
duopa
fda
hereditary transthyretin amyloidosis
inbrija
inotersen
john maraganore
mylan
new york
nobel prize
onpattro
parkinson's disease
patisiran
paul matteis
pfizer
rna interference
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
stiel
sunovion pharmaceuticals
What
approved
2
×
drug
2
×
fda
gets
2
×
acorda
afternoon
alnylam
alnylam’s
cope
disease
episodes
friday
help
history
landmark
late
looms
making
meant
medications
medicine
new
nod
ok
onpattro
parkinson’s
patients
patisiran
pharmaceuticals
rival
rnai
specifically
stop
treatment
working
Language
Current search:
gets
×
drug
×
approved
×
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug